Moore Capital Management, LP Iovance Biotherapeutics, Inc. Transaction History

Moore Capital Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $408,249 - $826,750	-25,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $716,750 - $1.31 Million	-25,000 Reduced 50.0%	25,000 $792,000
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $4.77 Million - $8.54 Million	-169,982 Reduced 77.27%	50,000 $2.32 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $4.72 Million - $6.17 Million	169,982 Added 339.96%	219,982 $7.24 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $680,250 - $1.03 Million	25,000 Added 100.0%	50,000 $1.37 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $2.17 Million - $4.31 Million	-111,040 Reduced 81.62%	25,000 $748,000
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $223,315 - $365,889	12,441 Added 10.07%	136,040 $3.77 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $874,296 - $1.26 Million	48,599 Added 64.8%	123,599 $2.25 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $733,500 - $1.84 Million	-75,000 Reduced 50.0%	75,000 $1.84 Million
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $187,750 - $298,250	25,000 Added 20.0%	150,000 $1.33 Million
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $843,750 - $1.33 Million	75,000 Added 150.0%	125,000 $1.41 Million
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $622,500 - $847,500	50,000 New	50,000 $640,000

319

243M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $923M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.